Walleye Trading LLC Akero Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $76,368 - $134,074	-4,300 Reduced 74.14%	1,500 $37,000
Q4 2023 Feb 14, 2024	SELL	$11.38 - $50.33 $298,156 - $1.32 Million	-26,200 Reduced 81.88%	5,800 $135,000
Q3 2023 Nov 14, 2023	SELL	$41.19 - $52.25 $1.22 Million - $1.55 Million	-29,700 Reduced 48.14%	32,000 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $2.02 Million - $3.11 Million	54,700 Added 781.43%	61,700 $2.88 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $197,531 - $266,272	5,300 Added 311.76%	7,000 $267,000
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $2.26 Million - $3.71 Million	-67,700 Reduced 97.55%	1,700 $93,000
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $704,410 - $2.36 Million	69,400 New	69,400 $2.36 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.